Taiko Pharmaceutical Co.,Ltd. (TYO:4574)

Taiko Pharmaceutical Revenue

Taiko Pharmaceutical had revenue of 1.72B JPY in the quarter ending June 30, 2026, with 36.29% growth. This brings the company's total for the last twelve months to 6.62B, up 13.30% year-over-year. In the year 2025, Taiko Pharmaceutical had annual revenue of 6.40B with 1.67% growth. That makes Taiko Pharmaceutical the 29,305th largest company in the world by revenue and 3,083rd in Japan.

• Revenue (ttm): 6.62B
• Revenue Growth: +13.30%
• P/S Ratio: 2.00
• Revenue / Employee: 30.10M
• Employees: 220
• Market Cap: 13.23B

Revenue Chart

Chart

Chart

Revenue by Segment

By Segment

Chart

• Pharmaceutical Business 5.77B 90.2%
• Infection Control Business 619.00M 9.7%
• Others Business 5.00M 0.1%

By Geography

Chart

• Japan 4.08B 63.8%
• China / Hong Kong 1.87B 29.3%
• Taiwan 337.00M 5.3%
• Others 105.00M 1.6%

Fiscal year ended Dec 31, 2025 See the full Taiko Pharmaceutical breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	6.40B	105.00M	1.67%
Dec 31, 2024	6.29B	172.00M	2.81%
Dec 31, 2023	6.12B	1.08B	21.43%
Dec 31, 2022	5.04B	-6.26B	-55.39%
Dec 31, 2021	11.30B	-11.16B	-49.68%

Data Source: S&P Global Market Intelligence Last updated: Aug 13, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 15, 2026

Data Sources Report a data error